Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 743.95
(-2.17%)
INR 743.95
(-2.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 931.91 Million INR | -28.48% |
| 2022 | 1.3 Billion INR | -45.7% |
| 2021 | 2.39 Billion INR | 476.37% |
| 2020 | 416.32 Million INR | 266.46% |
| 2019 | -250.1 Million INR | -1055.04% |
| 2018 | 26.18 Million INR | 100.51% |
| 2017 | -5.15 Billion INR | -693.27% |
| 2016 | 868.66 Million INR | 450.48% |
| 2015 | 157.8 Million INR | 411.74% |
| 2014 | -50.61 Million INR | 80.87% |
| 2013 | -264.66 Million INR | -1191.09% |
| 2012 | 24.25 Million INR | -94.74% |
| 2011 | 461.42 Million INR | 29.6% |
| 2010 | 356.04 Million INR | 193.32% |
| 2009 | 121.38 Million INR | 126.4% |
| 2008 | 53.61 Million INR | -62.42% |
| 2007 | 142.66 Million INR | 1782.31% |
| 2006 | -8.48 Million INR | 98.51% |
| 2005 | -570.89 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.27 Billion INR | 21.47% |
| 2023 Q1 | 1.86 Billion INR | 43.44% |
| 2023 Q4 | 931.91 Million INR | 40.91% |
| 2023 FY | 931.91 Million INR | -28.48% |
| 2023 Q3 | 661.37 Million INR | -70.87% |
| 2022 Q4 | 1.3 Billion INR | -61.69% |
| 2022 FY | 1.3 Billion INR | -45.7% |
| 2022 Q2 | -269.59 Million INR | -107.23% |
| 2022 Q1 | 3.72 Billion INR | 55.35% |
| 2022 Q3 | 3.4 Billion INR | 1361.59% |
| 2021 Q2 | 1.6 Billion INR | -48.88% |
| 2021 FY | 2.39 Billion INR | 476.37% |
| 2021 Q3 | 2.1 Billion INR | 31.19% |
| 2021 Q4 | 2.39 Billion INR | 13.99% |
| 2021 Q1 | 3.13 Billion INR | 653.96% |
| 2020 Q2 | 115.17 Million INR | -98.22% |
| 2020 FY | 416.32 Million INR | 266.46% |
| 2020 Q4 | 416.32 Million INR | -89.82% |
| 2020 Q3 | 4.08 Billion INR | 3450.59% |
| 2020 Q1 | 6.45 Billion INR | 2680.18% |
| 2019 Q4 | -250.1 Million INR | -103.17% |
| 2019 FY | -250.1 Million INR | -1055.04% |
| 2019 Q3 | 7.88 Billion INR | 1031.83% |
| 2019 Q2 | -845.69 Million INR | -108.48% |
| 2019 Q1 | 9.97 Billion INR | 38001.34% |
| 2018 FY | 26.18 Million INR | 100.51% |
| 2018 Q1 | 15.61 Billion INR | 403.02% |
| 2018 Q4 | 26.18 Million INR | 0.0% |
| 2017 Q3 | -8.02 Billion INR | 0.0% |
| 2017 FY | -5.15 Billion INR | -693.27% |
| 2017 Q4 | -5.15 Billion INR | 35.81% |
| 2016 Q4 | 868.66 Million INR | 0.0% |
| 2016 FY | 868.66 Million INR | 450.48% |
| 2015 FY | 157.8 Million INR | 411.74% |
| 2014 FY | -50.61 Million INR | 80.87% |
| 2013 FY | -264.66 Million INR | -1191.09% |
| 2012 FY | 24.25 Million INR | -94.74% |
| 2011 FY | 461.42 Million INR | 29.6% |
| 2010 FY | 356.04 Million INR | 193.32% |
| 2009 FY | 121.38 Million INR | 126.4% |
| 2008 FY | 53.61 Million INR | -62.42% |
| 2007 FY | 142.66 Million INR | 1782.31% |
| 2006 FY | -8.48 Million INR | 98.51% |
| 2005 FY | -570.89 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | -954.9 Million INR | 197.593% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 474.576% |
| Sigachi Industries Limited | 859.94 Million INR | -8.369% |
| Bal Pharma Limited | 1.26 Billion INR | 26.247% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 122.439% |
| Medico Remedies Limited | 78.67 Million INR | -1084.483% |
| Lasa Supergenerics Limited | 205.79 Million INR | -352.828% |
| Venus Remedies Limited | -267.7 Million INR | 448.12% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 198.951% |
| Alpa Laboratories Limited | 35.36 Million INR | -2535.285% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 84.865% |
| Shilpa Medicare Limited | 9.06 Billion INR | 89.725% |
| Aarti Drugs Limited | 5.54 Billion INR | 83.204% |
| Lupin Limited | 17.19 Billion INR | 94.579% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 74.767% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 76.178% |
| Windlas Biotech Limited | -273.04 Million INR | 441.311% |
| Suven Life Sciences Limited | -1.63 Billion INR | 157.078% |
| Eris Lifesciences Limited | 13.8 Billion INR | 93.25% |
| Valiant Laboratories Limited | -295.03 Million INR | 415.869% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 66.967% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 90.708% |
| Ipca Laboratories Limited | 11.41 Billion INR | 91.836% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 180.494% |
| Achyut Healthcare Limited | -3.74 Million INR | 24977.629% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 101.286% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 71.751% |
| RPG Life Sciences Limited | -364.7 Million INR | 355.529% |
| Mankind Pharma Limited | -9.9 Billion INR | 109.406% |
| Laurus Labs Limited | 24.38 Billion INR | 96.178% |
| Piramal Pharma Limited | 42.27 Billion INR | 97.796% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -1916.654% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 97.072% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 75.894% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 121.747% |
| Sequent Scientific Limited | 4.17 Billion INR | 77.698% |
| Novartis India Limited | -5.89 Billion INR | 115.819% |
| Wanbury Limited | 1.1 Billion INR | 15.73% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -542.807% |
| Wockhardt Limited | 18.27 Billion INR | 94.899% |
| Themis Medicare Limited | 764.96 Million INR | -21.825% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 167.048% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 96.558% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 132.783% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 92.783% |
| Divi's Laboratories Limited | -39.77 Billion INR | 102.343% |
| NATCO Pharma Limited | -5.81 Billion INR | 116.021% |
| Gufic Biosciences Limited | 3.19 Billion INR | 70.826% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 184.62% |
| Ind-Swift Limited | 9.5 Billion INR | 90.199% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 139.69% |
| FDC Limited | -57.75 Million INR | 1713.651% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 51.787% |
| Granules India Limited | 9.28 Billion INR | 89.965% |
| Medicamen Biotech Limited | 160.31 Million INR | -481.299% |
| Alkem Laboratories Limited | -1.6 Billion INR | 157.905% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 118.592% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 5152.131% |
| Brooks Laboratories Limited | 49.48 Million INR | -1783.229% |
| Megasoft Limited | 1.28 Billion INR | 27.508% |
| ZIM Laboratories Limited | 983.6 Million INR | 5.255% |
| Strides Pharma Science Limited | 23.25 Billion INR | 95.993% |
| Neuland Laboratories Limited | -214.05 Million INR | 535.357% |
| Morepen Laboratories Limited | -231.17 Million INR | 503.123% |
| Hikal Limited | 7.96 Billion INR | 88.303% |
| Indoco Remedies Limited | 6.47 Billion INR | 85.61% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 64.32% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -676.344% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 4.498% |
| Hester Biosciences Limited | 2.29 Billion INR | 59.318% |